1,056 filings
Page 4 of 53
8-K
l7samtwae2y owh
14 Dec 21
Regulation FD Disclosure
7:08am
8-K
bq2od ii1uk2hy
9 Dec 21
Labcorp Announces Initiatives to Enhance Shareholder Value
7:07am
8-K
ldtbow1
2 Nov 21
Labcorp to Speak at Credit Suisse 30TH Annual Healthcare Conference
4:40pm
8-K
36pt4ag8vm
28 Oct 21
Labcorp Announces 2021 Third Quarter Results
8:59am
8-K
axjlpqv
28 Sep 21
Regulation FD Disclosure
4:38pm
8-K
35dpcvrdpqq53
13 Sep 21
Labcorp Completes Acquisition of Myriad Autoimmune's Vectra Testing Business
4:39pm
8-K
ohf4wo7monxkqi1s
8 Sep 21
Labcorp to Speak at Morgan Stanley 19TH Annual Global Healthcare Conference
4:24pm
8-K
8dc7wqeke5ix0aok8sth
13 Aug 21
Labcorp Extends Leadership In Women’s Health with Acquisition of Ovia Health
12:00am
8-K
c2yk oxwdldd04e
29 Jul 21
Labcorp Announces 2021 Second Quarter Results
8:36am
8-K
mtmdssrk
2 Jul 21
Regulation FD Disclosure
3:57pm
8-K
vz5el1xgrro4nh
26 May 21
Entry into a Material Definitive Agreement
5:04pm
8-K
buf12c6ac
18 May 21
Labcorp to Speak at Ubs Global Healthcare Virtual Conference
8:50am
8-K
qh7eh4up 1nei
14 May 21
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
hco640v9g1j44pla6
14 May 21
Labcorp Prices $500,000,000 In 1.550% Senior Notes Due 2026 and $500,000,000 In 2.700% Senior Notes Due 2031
12:00am
8-K
o6kjs 5mznvd
12 May 21
Labcorp Announces Proposed Sale of Senior Notes
9:54am
8-K
cdva3a3info2ozuwbupo
29 Apr 21
Labcorp Announces 2021 First Quarter Results
8:42am
8-K
4rsc9t1l5qe977obx8qd
16 Apr 21
Labcorp to Webcast Its Annual Meeting of Shareholders
8:59am
8-K/A
emo4e8yx
31 Mar 21
Departure of Directors or Certain Officers
8:34am
8-K
web 08gwys76
30 Mar 21
Regulation FD Disclosure
12:00am
8-K
xojp1ee13
26 Mar 21
Labcorp Appoints Johnson & Johnson Executive Kathryn Wengel
7:37am